Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.

de With K, Allerberger F, Amann S, Apfalter P, Brodt HR, Eckmanns T, Fellhauer M, Geiss HK, Janata O, Krause R, Lemmen S, Meyer E, Mittermayer H, Porsche U, Presterl E, Reuter S, Sinha B, Strauß R, Wechsler-Fördös A, Wenisch C, Kern WV.

Infection. 2016 Jun;44(3):395-439. doi: 10.1007/s15010-016-0885-z.

2.

Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia.

Lubell Y, Blacksell SD, Dunachie S, Tanganuchitcharnchai A, Althaus T, Watthanaworawit W, Paris DH, Mayxay M, Peto TJ, Dondorp AM, White NJ, Day NP, Nosten F, Newton PN, Turner P.

BMC Infect Dis. 2015 Nov 11;15:511. doi: 10.1186/s12879-015-1272-6.

3.

Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients.

Lee WS, Kang DW, Back JH, Kim HL, Chung JH, Shin BC.

Korean J Intern Med. 2015 Mar;30(2):198-204. doi: 10.3904/kjim.2015.30.2.198. Epub 2015 Feb 27.

4.

Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem.

Llor C, Bjerrum L.

Ther Adv Drug Saf. 2014 Dec;5(6):229-41. doi: 10.1177/2042098614554919. Review.

5.

Biomarkers for sepsis: a review with special attention to India.

Nelson GE, Mave V, Gupta A.

Biomed Res Int. 2014;2014:264351. doi: 10.1155/2014/264351. Epub 2014 Mar 19. Review.

6.

Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial.

Tang J, Long W, Yan L, Zhang Y, Xie J, Lu G, Yang C.

BMC Infect Dis. 2013 Dec 17;13:596. doi: 10.1186/1471-2334-13-596.

7.

Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis.

Prkno A, Wacker C, Brunkhorst FM, Schlattmann P.

Crit Care. 2013 Dec 11;17(6):R291. doi: 10.1186/cc13157. Review.

8.

Kinetics of procalcitonin and C-reactive protein and the relationship to postoperative infection in young infants undergoing cardiovascular surgery.

Davidson J, Tong S, Hauck A, Lawson DS, da Cruz E, Kaufman J.

Pediatr Res. 2013 Oct;74(4):413-9. doi: 10.1038/pr.2013.124. Epub 2013 Jul 17.

9.

Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock.

Hohn A, Schroeder S, Gehrt A, Bernhardt K, Bein B, Wegscheider K, Hochreiter M.

BMC Infect Dis. 2013 Apr 1;13:158. doi: 10.1186/1471-2334-13-158.

10.

Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study.

Uusitalo-Seppälä R, Huttunen R, Aittoniemi J, Koskinen P, Leino A, Vahlberg T, Rintala EM.

PLoS One. 2013;8(1):e53661. doi: 10.1371/journal.pone.0053661. Epub 2013 Jan 14.

11.

Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Gupta D, Agarwal R, Aggarwal AN, Singh N, Mishra N, Khilnani GC, Samaria JK, Gaur SN, Jindal SK; Pneumonia Guidelines Working Group.

Lung India. 2012 Jul;29(Suppl 2):S27-62. No abstract available.

12.

Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.

Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Mueller B.

Clin Infect Dis. 2012 Sep;55(5):651-62. doi: 10.1093/cid/cis464. Epub 2012 May 9.

13.
14.

Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions.

Venet F, Lepape A, Monneret G.

Crit Care. 2011;15(5):231. doi: 10.1186/cc10333. Epub 2011 Oct 7. Review.

15.

Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections.

Li H, Luo YF, Blackwell TS, Xie CM.

Antimicrob Agents Chemother. 2011 Dec;55(12):5900-6. doi: 10.1128/AAC.00335-11. Epub 2011 Sep 26. Review.

16.

Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.

Lacoma A, Prat C, Andreo F, Lores L, Ruiz-Manzano J, Ausina V, Domínguez J.

Int J Chron Obstruct Pulmon Dis. 2011;6:157-69. doi: 10.2147/COPD.S16070. Epub 2011 Feb 28.

17.

Biomarkers for ventilator-associated pneumonia: review of the literature.

Palazzo SJ, Simpson T, Schnapp L.

Heart Lung. 2011 Jul-Aug;40(4):293-8. doi: 10.1016/j.hrtlng.2010.11.003. Epub 2011 Mar 21. Review.

18.

Impact of an antibiotic restriction program on antibiotic utilization in the treatment of community-acquired pneumonia in a Veterans Affairs Medical Center.

Mansouri MD, Cadle RM, Agbahiwe SO, Musher DM.

Infection. 2011 Feb;39(1):53-8. doi: 10.1007/s15010-010-0078-0. Epub 2011 Feb 12.

Supplemental Content

Support Center